American clinical stage biopharmaceutical company in San Diego, California, listed on Nasdaq and devoted to women's health. Develops products in contraception, fertility, sexual health and vaginal and reproductive health, including Xaciato, a clindamycin vaginal gel for bacterial vaginosis licensed to Organon, and candidates in hormone free contraception, endometriosis and vulvovaginal conditions, in licensing and partnering programmes from academic and industry originators.
Aucun commentaire disponible.
Laissez votre note & commentaire